首页 > 市场调查报告书 > 医疗设备

生技设备

分子生物学用酵素、套件、试剂市场规模，占有率，趋势分析:各产品，各用途，各终端用户，各地区展望，竞争策略，至2030年的各市场区隔预测

市场调查报告书

商品编码

1089966

分子生物学用酵素、套件、试剂市场规模，占有率，趋势分析:各产品，各用途，各终端用户，各地区展望，竞争策略，至2030年的各市场区隔预测

Molecular Biology Enzymes & Kits & Reagents Market Size, Share & Trends Analysis By Product, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

出版日期: 2022年06月14日 | 出版商:

SPER Market Research Pvt. Ltd. | 英文 256 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

全球分子生物学用酵素、套件、试剂的市场规模，预计今后以13.6％的年复合成长率扩大，至2030年达到482亿1,000万美元。研究的活跃，投资，基因计划增加，生命科学产业上技术的进步，遗传性疾病的发生率上升等，成为市场扩大的要素。

本报告提供全球分子生物学用酵素、套件、试剂市场相关调查，市场概要，以及各产品，各用途，各终端用户，各地区的趋势，及加入此市场的主要企业的简介等资讯。

ADS Biotec Inc.
Agilent
Aldevron
Bio Basic
Bio-Rad Laboratories Inc
Genekam Biotechnology
Goldsite Diagnostics Inc.
Hangzhou Matridx Biotechnology Co. Ltd.
Illumina
Integrated DNA Technologies, Inc.
Jena Bioscience
LGC Biosearch Technologies
Lucigen Corporation
Merck
MoBiTec GmbH
Molecular Biology Resources
New England Biolabs
NZYTech
Promega
QIAGEN
Randox
Roche
Takara Bio
Thermo Fisher
Zymo Research Corporation

简介目录

Product Code: BIOT2232

Global Molecular Biology Enzymes & Kits & Reagents Market projected to be worth USD 48.21 billion by 2030.

According to SPER Market Research, the Molecular Biology Enzymes & Kits & Reagents Market estimated to reach USD 48.21 billion by 2030 with a CAGR of 13.6%. Amplified research, investments, increasing number of genome projects, technological advancement in the life science industry, and growing incidence of genetic disorders; are the fuels for the escalation of the market.

Impact of COVID-19 on the Molecular Biology Enzymes & Kits & Reagents Market

The outbreak of COVID-19 gives a positive impact to the expansion Molecular Biology Enzymes & Kits & Reagents Market.

Scope of the report:

Market size available for years: 2019-2030

Base year considered: 2021

Forecast period: 2022-2030

Segments covered: By Material, By Technique, By Application, By End-Users, By Region

Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa

Companies Covered: ADS Biotec Inc., Agilent, Aldevron, Bio Basic, Bio-Rad Laboratories, Inc.¸Genekam Biotechnology, Goldsite Diagnostics Inc., Hangzhou Matridx Biotechnology Co. Ltd., Illumina, Integrated DNA Technologies, Inc., Jena Bioscience, LGC Biosearch Technologies, Lucigen Corporation, Merck, MoBiTec GmbH, Molecular Biology Resources, New England Biolabs, NZYTech, Promega, QIAGEN, Randox, Roche, Takara Bio, Thermo Fisher, Zymo Research Corporation

Driver: increasing number of genome projects

The increasing numeral of genome projects globally, tied with dipping genetic analysis costs; leads to advancement in research in diverse fields like; personalized medicine, microbial genetic, disease treatment. This research need the use of molecular biology enzymes and reagents, consequently impel the expansion of this molecular biology enzymes and kits & reagents market.

Restraints: restricted reimbursements for genetic testing

The inflexible reimbursement policy is the restraints to this market.

Opportunity: Research & Development investments offer significant opportunities for the market

Increase in the funds & grants from the government, advancement in the genomic technological facade, investments in research & development have vast opportunities for this market.

Molecular Biology Enzymes & Kits & Reagents Market, By Product:

Based on the Product, Molecular Biology Enzymes & Kits & Reagents Market is segmented as; Kits & Reagents, Enzymes, Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Other Enzymes.

Molecular Biology Enzymes & Kits & Reagents Market, By Application:

Based on the Application, Molecular Biology Enzymes & Kits & Reagents Market is segmented as; PCR, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology, Other Applications.

Molecular Biology Enzymes & Kits & Reagents Market, By End User:

Based on the End-Users, Molecular Biology Enzymes & Kits & Reagents Market is segmented as; Academic & Research Institutes, Pharmaceutical & Biotechnology companies, Hospitals & Diagnostic Centers, Other End Users.

Molecular Biology Enzymes & Kits & Reagents Market, By Region:

North America dominates the biggest share of this market; this is due to the increase in funding of translational and clinical research, increasing the figure of pharmaceutical and biotechnology companies, rising investments in research projects in Canada favourable reimbursement scenario.

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER's internal database
- 2.1.4 Premium insight from KOL's
2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
4.2. COVID-19 Impacts of the Molecular Biology Enzymes & Kits & Reagents Market

5. Market variables and outlook

5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
5.3. PORTER'S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Molecular Biology Enzymes & Kits & Reagents Market, By Product, 2019-2030 (USD Million)

6.1. Kits & Reagents
6.2. Enzymes
6.3. Polymerases
6.4. Ligases
6.5. Restriction Endonucleases
6.6. Reverse Transcriptases
6.7. Other Enzymes

7. Molecular Biology Enzymes & Kits & Reagents Market, By Application, 2019-2030 (USD Million)

7.1. PCR
7.2. Sequencing
7.3. Cloning
7.4. Epigenetics
7.5. Restriction Digestion
7.6. Synthetic Biology
7.7. Other Applications

8. Molecular Biology Enzymes & Kits & Reagents Market, By End User, 2019-2030 (USD Million)

8.1. Academic & Research Institutes
8.2. Pharmaceutical & Biotechnology companies
8.3. Hospitals & Diagnostic Centers
8.4. Other End Users

9. Molecular Biology Enzymes & Kits & Reagents Market, By Region, 2019-2030 (USD Million)

9.1. North America
- 9.1.1. United States
- 9.1.2. Canada
- 9.1.3. Mexico
9.2. Europe
- 9.2.1. Germany
- 9.2.2. United Kingdom
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Australia
- 9.3.5. South Korea
- 9.3.6. Rest of Asia-Pacific
9.4. South America
- 9.4.1. Brazil
- 9.4.2. Argentina
- 9.4.3. Rest of South America
9.5. Middle East & Africa
- 9.5.1. Kingdom of Saudi Arabia
- 9.5.2. United Arab Emirates
- 9.5.3. Rest of Middle East & Africa

10. Company Profiles

10.1. ADS Biotec Inc.
- 10.1.1. Company details
- 10.1.2. Financial outlook
- 10.1.3. Product summary
- 10.1.4. Recent developments
10.2. Agilent
- 10.2.1. Company details
- 10.2.2. Financial outlook
- 10.2.3. Product summary
- 10.2.4. Recent developments
10.3. Aldevron
- 10.3.1. Company details
- 10.3.2. Financial outlook
- 10.3.3. Product summary
- 10.3.4. Recent developments
10.4. Bio Basic
- 10.4.1. Company details
- 10.4.2. Financial outlook
- 10.4.3. Product summary
- 10.4.4. Recent developments
10.5. Bio-Rad Laboratories Inc.
- 10.5.1. Company details
- 10.5.2. Financial outlook
- 10.5.3. Product summary
- 10.5.4. Recent developments
10.6. Genekam Biotechnology
- 10.6.1. Company details
- 10.6.2. Financial outlook
- 10.6.3. Product summary
- 10.6.4. Recent developments
10.7. Goldsite Diagnostics Inc.
- 10.7.1. Company details
- 10.7.2. Financial outlook
- 10.7.3. Product summary
- 10.7.4. Recent developments
10.8. Hangzhou Matridx Biotechnology Co. Ltd.
- 10.8.1. Company details
- 10.8.2. Financial outlook
- 10.8.3. Product summary
- 10.8.4. Recent developments
10.9. Illumina
- 10.9.1. Company details
- 10.9.2. Financial outlook
- 10.9.3. Product summary
- 10.9.4. Recent developments
10.10. Integrated DNA Technologies, Inc.
- 10.10.1. Company details
- 10.10.2. Financial outlook
- 10.10.3. Product summary
- 10.10.4. Recent developments
10.11. Jena Bioscience
- 10.11.1. Company details
- 10.11.2. Financial outlook
- 10.11.3. Product summary
- 10.11.4. Recent developments
10.12. LGC Biosearch Technologies
- 10.12.1. Company details
- 10.12.2. Financial outlook
- 10.12.3. Product summary
- 10.12.4. Recent developments
10.13. Lucigen Corporation
- 10.13.1. Company details
- 10.13.2. Financial outlook
- 10.13.3. Product summary
- 10.13.4. Recent developments
10.14. Merck
- 10.14.1. Company details
- 10.14.2. Financial outlook
- 10.14.3. Product summary
- 10.14.4. Recent developments
10.15. MoBiTec GmbH
- 10.15.1. Company details
- 10.15.2. Financial outlook
- 10.15.3. Product summary
- 10.15.4. Recent developments
10.16. Molecular Biology Resources
- 10.16.1. Company details
- 10.16.2. Financial outlook
- 10.16.3. Product summary
- 10.16.4. Recent developments
10.17. New England Biolabs
- 10.17.1. Company details
- 10.17.2. Financial outlook
- 10.17.3. Product summary
- 10.17.4. Recent developments
10.18. NZYTech
- 10.18.1. Company details
- 10.18.2. Financial outlook
- 10.18.3. Product summary
- 10.18.4. Recent developments
10.19. Promega
- 10.19.1. Company details
- 10.19.2. Financial outlook
- 10.19.3. Product summary
- 10.19.4. Recent developments
10.20. QIAGEN
- 10.20.1. Company details
- 10.20.2. Financial outlook
- 10.20.3. Product summary
- 10.20.4. Recent developments
10.21. Randox
- 10.21.1. Company details
- 10.21.2. Financial outlook
- 10.21.3. Product summary
- 10.21.4. Recent developments
10.22. Roche
- 10.22.1. Company details
- 10.22.2. Financial outlook
- 10.22.3. Product summary
- 10.22.4. Recent developments
10.23. Takara Bio
- 10.23.1. Company details
- 10.23.2. Financial outlook
- 10.23.3. Product summary
- 10.23.4. Recent developments
10.24. Thermo Fisher
- 10.24.1. Company details
- 10.24.2. Financial outlook
- 10.24.3. Product summary
- 10.24.4. Recent developments
10.25. Zymo Research Corporation
- 10.25.1. Company details
- 10.25.2. Financial outlook
- 10.25.3. Product summary
- 10.25.4. Recent developments

9. Molecular Biology Enzymes & Kits & Reagents Market, By Region, 2019-2030 (USD Million)

9.1. North America
- 9.1.1. United States
- 9.1.2. Canada
- 9.1.3. Mexico
9.2. Europe
- 9.2.1. Germany
- 9.2.2. United Kingdom
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Australia
- 9.3.5. South Korea
- 9.3.6. Rest of Asia-Pacific
9.4. South America
- 9.4.1. Brazil
- 9.4.2. Argentina
- 9.4.3. Rest of South America
9.5. Middle East & Africa
- 9.5.1. Kingdom of Saudi Arabia
- 9.5.2. United Arab Emirates
- 9.5.3. Rest of Middle East & Africa

10. Company Profiles

10.1. ADS Biotec Inc.
- 10.1.1. Company details
- 10.1.2. Financial outlook
- 10.1.3. Product summary
- 10.1.4. Recent developments
10.2. Agilent
- 10.2.1. Company details
- 10.2.2. Financial outlook
- 10.2.3. Product summary
- 10.2.4. Recent developments
10.3. Aldevron
- 10.3.1. Company details
- 10.3.2. Financial outlook
- 10.3.3. Product summary
- 10.3.4. Recent developments
10.4. Bio Basic
- 10.4.1. Company details
- 10.4.2. Financial outlook
- 10.4.3. Product summary
- 10.4.4. Recent developments
10.5. Bio-Rad Laboratories Inc.
- 10.5.1. Company details
- 10.5.2. Financial outlook
- 10.5.3. Product summary
- 10.5.4. Recent developments
10.6. Genekam Biotechnology
- 10.6.1. Company details
- 10.6.2. Financial outlook
- 10.6.3. Product summary
- 10.6.4. Recent developments
10.7. Goldsite Diagnostics Inc.
- 10.7.1. Company details
- 10.7.2. Financial outlook
- 10.7.3. Product summary
- 10.7.4. Recent developments
10.8. Hangzhou Matridx Biotechnology Co. Ltd.
- 10.8.1. Company details
- 10.8.2. Financial outlook
- 10.8.3. Product summary
- 10.8.4. Recent developments
10.9. Illumina
- 10.9.1. Company details
- 10.9.2. Financial outlook
- 10.9.3. Product summary
- 10.9.4. Recent developments
10.10. Integrated DNA Technologies, Inc.
- 10.10.1. Company details
- 10.10.2. Financial outlook
- 10.10.3. Product summary
- 10.10.4. Recent developments
10.11. Jena Bioscience
- 10.11.1. Company details
- 10.11.2. Financial outlook
- 10.11.3. Product summary
- 10.11.4. Recent developments
10.12. LGC Biosearch Technologies
- 10.12.1. Company details
- 10.12.2. Financial outlook
- 10.12.3. Product summary
- 10.12.4. Recent developments
10.13. Lucigen Corporation
- 10.13.1. Company details
- 10.13.2. Financial outlook
- 10.13.3. Product summary
- 10.13.4. Recent developments
10.14. Merck
- 10.14.1. Company details
- 10.14.2. Financial outlook
- 10.14.3. Product summary
- 10.14.4. Recent developments
10.15. MoBiTec GmbH
- 10.15.1. Company details
- 10.15.2. Financial outlook
- 10.15.3. Product summary
- 10.15.4. Recent developments
10.16. Molecular Biology Resources
- 10.16.1. Company details
- 10.16.2. Financial outlook
- 10.16.3. Product summary
- 10.16.4. Recent developments
10.17. New England Biolabs
- 10.17.1. Company details
- 10.17.2. Financial outlook
- 10.17.3. Product summary
- 10.17.4. Recent developments
10.18. NZYTech
- 10.18.1. Company details
- 10.18.2. Financial outlook
- 10.18.3. Product summary
- 10.18.4. Recent developments
10.19. Promega
- 10.19.1. Company details
- 10.19.2. Financial outlook
- 10.19.3. Product summary
- 10.19.4. Recent developments
10.20. QIAGEN
- 10.20.1. Company details
- 10.20.2. Financial outlook
- 10.20.3. Product summary
- 10.20.4. Recent developments
10.21. Randox
- 10.21.1. Company details
- 10.21.2. Financial outlook
- 10.21.3. Product summary
- 10.21.4. Recent developments
10.22. Roche
- 10.22.1. Company details
- 10.22.2. Financial outlook
- 10.22.3. Product summary
- 10.22.4. Recent developments
10.23. Takara Bio
- 10.23.1. Company details
- 10.23.2. Financial outlook
- 10.23.3. Product summary
- 10.23.4. Recent developments
10.24. Thermo Fisher
- 10.24.1. Company details
- 10.24.2. Financial outlook
- 10.24.3. Product summary
- 10.24.4. Recent developments
10.25. Zymo Research Corporation
- 10.25.1. Company details
- 10.25.2. Financial outlook
- 10.25.3. Product summary
- 10.25.4. Recent developments

02-2729-4219

+886-2-2729-4219

License/价格

分子生物学用酵素、套件、试剂市场规模，占有率，趋势分析:各产品，各用途，各终端用户，各地区展望，竞争策略，至2030年的各市场区隔预测

Molecular Biology Enzymes & Kits & Reagents Market Size, Share & Trends Analysis By Product, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

目录

第1章简介

第2章调查手法

第3章摘要整理

第4章市场动态

第5章市场变数及预测

第6章分子生物学用酵素、套件、试剂市场，各产品，2019年～2030年(100万美元)

第7章分子生物学用酵素、套件、试剂市场，各用途，2019年～2030年(100万美元)

第8章分子生物学用酵素、套件、试剂市场，各终端用户，2019年～2030年(100万美元)

第9章分子生物学用酵素、套件、试剂市场，各地区，2019年～2030年(100万美元)

第10章企业简介

Global Molecular Biology Enzymes & Kits & Reagents Market projected to be worth USD 48.21 billion by 2030.

Impact of COVID-19 on the Molecular Biology Enzymes & Kits & Reagents Market